InsiderClue
← All stocks

Kiniksa Pharmaceuticals International, plc

KNSA Mostly scheduled
CIK 0001730430 #1216 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$61.90M
$1.38M on a plan · $60.22M straight out of an exercise
Sold at will
$299.09K
1 of 48 sales
Net
−$61.90M
−$299.09K against sales at will

By person

13 insiders · 49 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Patel Sanj K
CHAIRMAN & CEO
—
$39.43M (12) scheduled
−$39.43M
1,205,731
1.6%
$96.82M
+436.0%
Paolini John F.
CHIEF MEDICAL OFFICER
—
$8.00M (6) scheduled
−$8.00M
69,922
0.090%
$5.61M
+34.4%
Ragosa Mark
CHIEF FINANCIAL OFFICER
—
$5.56M (8) scheduled
−$5.56M
20,854
0.027%
$1.67M
−29.4%
Tessari Eben
CHIEF STRATEGY OFFICER
—
$3.10M (7) scheduled
−$3.10M
23,130
0.030%
$1.86M
−81.4%
Quart Barry D
Director
—
$2.68M (8) scheduled
−$2.68M
12,745
0.016%
$1.02M
+36.0%
Megna Michael R
CHIEF ACCOUNTING OFFICER
—
$2.64M (4) scheduled
−$2.64M
29,062
0.037%
$2.33M
+9.9%
Cole G Bradley
Director
—
$299.09K (1)
−$299.09K
7,172
0.009%
$575.91K
−23.5%
Moat Ross
CHIEF OPERATING OFFICER
—
$194.50K (2) scheduled
−$194.50K
16,307
0.021%
$1.31M
−25.0%
BAKER BROS. ADVISORS LP entity
Director
—
—
—
2,744,894
3.5%
$220.41M
+1.4%
Levy Richard S
Director
—
—
—
22,359
0.029%
$1.80M
+73.4%
Popovits Kimberly J
Director
—
—
—
15,345
0.020%
$1.23M
+63.7%
McCain Tracey L
Director
—
—
—
15,345
0.020%
$1.23M
+63.7%
Malley Thomas
Director
—
—
—
15,345
0.020%
$1.23M
+63.7%

Individual transactions

49
Insider
Date
Role
Action
Shares
Price
Amount
Megna Michael R
3 Sep 2026
CHIEF ACCOUNTING OFFICER
Sold on a plan
4,600
$80.30
$369.38K
Cole G Bradley
29 Jul 2026
Director
Sell
3,673
$81.43
$299.09K
Patel Sanj K
1 May 2026
CHAIRMAN & CEO
Sold after exercise
48,565
$54.02
$2.62M
Paolini John F.
1 May 2026
CHIEF MEDICAL OFFICER
Sold after exercise
21,097
$54.04
$1.14M
Paolini John F.
1 May 2026
CHIEF MEDICAL OFFICER
Sold after exercise
37,327
$53.52
$2.00M
Patel Sanj K
30 Apr 2026
CHAIRMAN & CEO
Sold after exercise
2,141
$54.01
$115.64K
Patel Sanj K
29 Apr 2026
CHAIRMAN & CEO
Sold after exercise
22,544
$54.01
$1.22M
Quart Barry D
28 Apr 2026
Director
Sold after exercise
13,099
$50.10
$656.26K
Patel Sanj K
28 Apr 2026
CHAIRMAN & CEO
Sold after exercise
51,750
$54.02
$2.80M
Patel Sanj K
28 Apr 2026
CHAIRMAN & CEO
Sold after exercise
243,596
$52.02
$12.67M
Patel Sanj K
28 Apr 2026
CHAIRMAN & CEO
Sold after exercise
113,673
$51.47
$5.85M
Patel Sanj K
28 Apr 2026
CHAIRMAN & CEO
Sold after exercise
74,635
$50.43
$3.76M
Moat Ross
9 Apr 2026
CHIEF OPERATING OFFICER
Sold on a plan
1,703
$46.69
$79.51K
Megna Michael R
9 Apr 2026
CHIEF ACCOUNTING OFFICER
Sold on a plan
6,625
$46.69
$309.32K
Megna Michael R
7 Apr 2026
CHIEF ACCOUNTING OFFICER
Exercised, kept
3,932
$1.00
$3.93K
Quart Barry D
6 Apr 2026
Director
Sold after exercise
6,901
$50.00
$345.05K
Moat Ross
6 Apr 2026
CHIEF OPERATING OFFICER
Sold on a plan
2,367
$48.58
$114.99K
Patel Sanj K
6 Apr 2026
CHAIRMAN & CEO
Sold after exercise
7,278
$50.01
$363.97K
Ragosa Mark
9 Mar 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
18,741
$46.24
$866.58K
Ragosa Mark
9 Mar 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
17,981
$45.58
$819.57K
Paolini John F.
2 Mar 2026
CHIEF MEDICAL OFFICER
Sold after exercise
5,714
$45.92
$262.39K
Paolini John F.
2 Mar 2026
CHIEF MEDICAL OFFICER
Sold after exercise
22,223
$44.88
$997.37K
Paolini John F.
2 Mar 2026
CHIEF MEDICAL OFFICER
Sold after exercise
12,063
$44.20
$533.18K
Quart Barry D
12 Feb 2026
Director
Sold after exercise
2,690
$45.00
$121.05K
Quart Barry D
10 Feb 2026
Director
Sold after exercise
110
$45.00
$4.95K
Ragosa Mark
9 Feb 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
8,731
$43.72
$381.72K
Ragosa Mark
9 Feb 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
9,114
$42.85
$390.53K
Quart Barry D
4 Feb 2026
Director
Sold after exercise
2,602
$45.02
$117.14K
Quart Barry D
3 Feb 2026
Director
Sold after exercise
12,528
$45.27
$567.14K
Quart Barry D
2 Feb 2026
Director
Sold after exercise
830
$45.00
$37.35K
Ragosa Mark
8 Jan 2026
CHIEF FINANCIAL OFFICER
Sold on a plan
12,000
$41.89
$502.68K
Tessari Eben
15 Dec 2025
CHIEF OPERATING OFFICER
Sold after exercise
12,048
$41.56
$500.71K
Quart Barry D
15 Dec 2025
Director
Sold after exercise
20,129
$41.51
$835.55K
Ragosa Mark
8 Dec 2025
CHIEF FINANCIAL OFFICER
Sold after exercise
42,841
$41.49
$1.78M
Tessari Eben
26 Nov 2025
CHIEF OPERATING OFFICER
Sold after exercise
200
$42.89
$8.58K
Tessari Eben
17 Nov 2025
CHIEF OPERATING OFFICER
Sold after exercise
11,825
$41.30
$488.37K
Tessari Eben
17 Nov 2025
CHIEF OPERATING OFFICER
Sold after exercise
645
$40.08
$25.85K
Ragosa Mark
12 Nov 2025
CHIEF FINANCIAL OFFICER
Sold after exercise
19,900
$40.94
$814.71K
Paolini John F.
31 Oct 2025
CHIEF MEDICAL OFFICER
Sold after exercise
82,542
$37.14
$3.07M
Ragosa Mark
28 Oct 2025
CHIEF FINANCIAL OFFICER
Sold after exercise
100
$41.00
$4.10K
Patel Sanj K
22 Oct 2025
CHAIRMAN & CEO
Sold after exercise
97,390
$38.83
$3.78M
Patel Sanj K
21 Oct 2025
CHAIRMAN & CEO
Sold after exercise
39,331
$38.77
$1.52M
Megna Michael R
20 Oct 2025
CHIEF ACCOUNTING OFFICER
Sold after exercise
13,235
$39.31
$520.27K
Megna Michael R
20 Oct 2025
CHIEF ACCOUNTING OFFICER
Sold after exercise
37,255
$38.72
$1.44M
Patel Sanj K
20 Oct 2025
CHAIRMAN & CEO
Sold after exercise
22,314
$39.32
$877.39K
Patel Sanj K
20 Oct 2025
CHAIRMAN & CEO
Sold after exercise
98,934
$38.81
$3.84M
Tessari Eben
14 Oct 2025
CHIEF OPERATING OFFICER
Sold after exercise
553
$37.99
$21.01K
Tessari Eben
14 Oct 2025
CHIEF OPERATING OFFICER
Sold after exercise
11,815
$37.65
$444.83K
Tessari Eben
29 Sep 2025
CHIEF OPERATING OFFICER
Sold after exercise
42,000
$38.33
$1.61M

What was left out

Form 4 filings counted 59
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 42
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 2,812,984
History held since 29 May 2018